Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from levetiracetam to brivaracetam for behavioral adverse effects in epilepsy
2011-005177-23Phase 3Completed
- Sponsor
- UCB
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of brivaracetam in epilepsy, sponsored by UCB. Started Apr 2012; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2011-005177-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005177-23.